Sign inJoin waitlistJoin the waitlist

MY

Mason Yamashita

Psychiatry & Neurology / Psychiatry

Credentials: ·

Research

Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
The Lancet · 2016 · 775 citations
AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer
Science Translational Medicine · 2015 · 397 citations
STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial
Journal for ImmunoTherapy of Cancer · 2018 · 221 citations

AY
Anas Younes
2 papers
David Hong
2 papers
JC
Jean Chan
2 papers
JN
John Nemunaitis
2 papers
Luis Fayad
2 papers
Mitchell Shiffman
2 papers
NF
Nathan Fowler
2 papers
Nikolaos Pyrsopoulos
2 papers
Razelle Kurzrock
2 papers
Sarina Piha-Paul
2 papers
Brian Borg
1 paper
CF
Catherine Frenette
1 paper